Home > Formulary : Paediatric > Paediatric Chapters > 1. Gastro-intestinal System >
BNSSG Paediatric Joint Formulary
1.4 Disorders of gastric acid and ulceration
Last edited: 16-07-2024
1.4.1 Dyspepsia
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
BNFc Dyspepsia
Alginates
Recommended:
Peptac® liquid (TLS Green)
- Peptac® liquid is sugar-free but contains 3.1mmol sodium per 5mL
Gaviscon® infant (TLS Green)
Antacids
BNFc Antacids
Simeticone (TLS Green)
Alternatives:
Co-magaldrox 195/220 suspension (Mucogel® - low in sodium) (TLS Blue)
Specific indication:
Sodium citrate (TLS Blue)
- Prophylaxis of acid aspiration
1.4.2 Gastric and duodenal ulceration
Peptic Ulceration
Chelates and Complexes
BNFc Chelates
Sucralfate (oral) (TLS Red)
Sucralfate enema (unlicensed) (TLS Red)
H2-receptor Antagonists
BNFc H2 receptor antagonists
Proton Pump Inhibitors
BNFc Proton pump inhibitors
MHRA warning on increased risk of fractures
MHRA warning on increased risk of hypomagnesaemia
Omeprazole capsules/dispersible tablets (TLS Green)
Omeprazole 20mg/5ml (4mg/ml) oral suspension sugar free (TLS Blue)
For Children aged under 1 year who are tube fed or children who require a dose of less than 10mg omeprazole only. Please refer to the BNSSG PPI prescribing pathway for children
Please note omeprazole 20mg/5ml (4mg/ml) oral suspension sugar free is non-formulary for all other cohorts. Omeprazole 10mg/5ml (2mg/ml) and 1mg/ml oral suspension sugar free are non-formulary.
Esomeprazole (intravenous infusion) (TLS Red)
Omeprazole (intravenous infusion) (TLS Red)
Pantoprazole (intravenous infusion) (TLS Red)
Alternative:
Lansoprazole capsules (TLS Blue)
Specific indications:
Lansoprazole fastabs (TLS Blue)
Esomeprazole tablets (TLS Blue)
- Endoscopically proven high grade oesophagitis
- Laryngeal reflux
- Patients with reflux associated cough who have not responded to omeprazole
Esomeprazole granules (TLS Blue)
- For paediatric patients with NG tubes, or second line in children with swallowing difficulties
1.4.3 Gastro-oesphageal reflux disease
BRCH Gastro-Oesophageal Reflux Disease Management guideline (available via link)
Specific Indication:
Domperidone (TLS blue) - for resistant patients used as per MHRA alert
Eosinophilic Oesophagitis
Budesonide orodispersible tablets (Jorveza®) (TLS Amber 3 months) (SCP click here)
Budesonide nebules (TLS Amber 3 months) (SCP click here)
- Mixed with water and Splenda® to form a slurry as detailed in SCP and leaflet
Patient leaflet- How to give budesonide nebules to your child for eosinophilic esophagitis
Fluticasone MDIs (TLS Red)